UnknownPhase 1

Effect of Buccal Fat Pad Derived Stem Cells in Maxillary Sinus Augmentation

Iran20 participantsStarted 2016-01

Plain-language summary

In this study the buccal fat pad derived stem cells (BFPSCs) will be harvested from buccal fat pad tissue of patients receiving maxillary sinus augmentation. In the test group the patients receive a combination of platelet rich fibrin (PRF) and freeze dried bone allograft (FDBA) (SureOss, Hansbiomed, Korea) loaded with BFPSCs. The results will be evaluated by cone beam computed tomography (CBCT)and hematoxylin and eosin staining in 6 months.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. patients with posterior maxillary edentulism
✓. pneumatized sinus
✓. less than 5mm bone height between the alveolar crest and sinus membrane

Exclusion criteria

✕. smoking
✕. history of malignancy
✕. radiation
✕. chemotherapy
✕. pregnancy
✕. systemic diseases contradicting dental and surgical treatments
✕. conditions or drugs affecting bone remodeling or bone metabolism and connective tissue
✕. allergy to collagen

What they're measuring

amount of regenerated bone

Timeframe: 6 months

amount of regenerated bone

Timeframe: 6 months

Trial details

NCT IDNCT02745379

SponsorShahid Beheshti University of Medical Sciences

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-12

Contact for this trial

Arash Khojasteh, DMD, OMFS

00989121060032 arashkhojasteh@yahoo.com

View on ClinicalTrials.gov More Alveolar Bone Loss trials